Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

New Venture Funds to Back Life Science, Tech Start-Ups

Investor screen

Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies. . . . → Read More: New Venture Funds to Back Life Science, Tech Start-Ups

Peptide Discovery Company to Gain $3.3B in Licensing Deals

Test tubes in a lab

A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals

AI Analytics Find New ALS Genetic Drug Targets

Artificial intelligence graphic

Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS. . . . → Read More: AI Analytics Find New ALS Genetic Drug Targets

AI Image Analysis Shown to Predict Embryo Health

IVF microscopic image

An algorithm designed to analyze microscopic images is shown to largely predict the genetic integrity of embryos from in-vitro fertilization. . . . → Read More: AI Image Analysis Shown to Predict Embryo Health

Roche, Global Fund to Build Local Diagnostic Processes

Transporting HIV tests

The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes

Biotech, Synthetic Bio Companies Partner on T-Cell Therapies

T-cells and cancer cells

A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics. . . . → Read More: Biotech, Synthetic Bio Companies Partner on T-Cell Therapies

Clinical Trial Set for AI-Driven Lung Fibrosis Drug

lung illustration

A clinical trial is set to begin testing the safety and chemical activity of a drug candidate for lung fibrosis, discovered and refined with artificial intelligence. . . . → Read More: Clinical Trial Set for AI-Driven Lung Fibrosis Drug

Pharma Company Licenses Protein Delivery Hydrogel

Gel sample

A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue. . . . → Read More: Pharma Company Licenses Protein Delivery Hydrogel

Trial Shows Immunotherapy Improves Lung Cancer Survival

Inspecting lung X-rays

Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy. . . . → Read More: Trial Shows Immunotherapy Improves Lung Cancer Survival

Infographic – Venture Funds More Than Double in 2021

Venture deals and dollars, Q4 2021

Venture funding worldwide rose sharply in 2021, with investment dollars climbing to nearly $621 billion, more than twice the total invested in 2020. . . . → Read More: Infographic – Venture Funds More Than Double in 2021